BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1313 related articles for article (PubMed ID: 26660118)

  • 1. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.
    Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R
    JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage.
    Lioutas VA; Goyal N; Katsanos AH; Krogias C; Zand R; Sharma VK; Varelas P; Malhotra K; Paciaroni M; Sharaf A; Chang J; Karapanayiotides T; Kargiotis O; Pappa A; Mai J; Pandhi A; Schroeder C; Tsantes A; Mehta C; Kerro A; Khan A; Mitsias PD; Selim MH; Alexandrov AV; Tsivgoulis G
    Stroke; 2018 Oct; 49(10):2309-2316. PubMed ID: 30355114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage.
    Gerner ST; Kuramatsu JB; Sembill JA; Sprügel MI; Endres M; Haeusler KG; Vajkoczy P; Ringleb PA; Purrucker J; Rizos T; Erbguth F; Schellinger PD; Fink GR; Stetefeld H; Schneider H; Neugebauer H; Röther J; Claßen J; Michalski D; Dörfler A; Schwab S; Huttner HB;
    Ann Neurol; 2018 Jan; 83(1):186-196. PubMed ID: 29314216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
    Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.
    Gerner ST; Kuramatsu JB; Sembill JA; Sprügel MI; Hagen M; Knappe RU; Endres M; Haeusler KG; Sobesky J; Schurig J; Zweynert S; Bauer M; Vajkoczy P; Ringleb PA; Purrucker JC; Rizos T; Volkmann J; Müllges W; Kraft P; Schubert AL; Erbguth F; Nueckel M; Schellinger PD; Glahn J; Knappe UJ; Fink GR; Dohmen C; Stetefeld H; Fisse AL; Minnerup J; Hagemann G; Rakers F; Reichmann H; Schneider H; Rahmig J; Ludolph AC; Stösser S; Neugebauer H; Röther J; Michels P; Schwarz M; Reimann G; Bäzner H; Schwert H; Claßen J; Michalski D; Grau A; Palm F; Urbanek C; Wöhrle JC; Alshammari F; Horn M; Bahner D; Witte OW; Günther A; Hamann GF; Engelhorn T; Lücking H; Dörfler A; Schwab S; Huttner HB
    Stroke; 2019 Jun; 50(6):1392-1402. PubMed ID: 31092170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants.
    Ip B; Pan S; Yuan Z; Hung T; Ko H; Leng X; Liu Y; Li S; Lee SY; Cheng C; Chan H; Mok V; Soo Y; Wu X; Lui LT; Chan R; Abrigo J; Dou Q; Seiffge D; Leung T
    JAMA Netw Open; 2024 Feb; 7(2):e2354916. PubMed ID: 38319661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome.
    Won SY; Dubinski D; Bruder M; Cattani A; Seifert V; Konczalla J
    Neurosurg Focus; 2017 Nov; 43(5):E12. PubMed ID: 29088960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage.
    Kuwashiro T; Yasaka M; Itabashi R; Nakagaki H; Miyashita F; Naritomi H; Minematsu K
    Cerebrovasc Dis; 2011; 31(2):170-6. PubMed ID: 21135553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebral Hemorrhagic Expansion Occurs in Patients Using Non-Vitamin K Antagonist Oral Anticoagulants Comparable with Patients Using Warfarin.
    Melmed KR; Lyden P; Gellada N; Moheet A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1874-1882. PubMed ID: 28647419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of intracerebral hemorrhage associated with different oral anticoagulants.
    Wilson D; Seiffge DJ; Traenka C; Basir G; Purrucker JC; Rizos T; Sobowale OA; Sallinen H; Yeh SJ; Wu TY; Ferrigno M; Houben R; Schreuder FHBM; Perry LA; Tanaka J; Boulanger M; Al-Shahi Salman R; Jäger HR; Ambler G; Shakeshaft C; Yakushiji Y; Choi PMC; Staals J; Cordonnier C; Jeng JS; Veltkamp R; Dowlatshahi D; Engelter ST; Parry-Jones AR; Meretoja A; Werring DJ;
    Neurology; 2017 May; 88(18):1693-1700. PubMed ID: 28381513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates.
    Huttner HB; Schellinger PD; Hartmann M; Köhrmann M; Juettler E; Wikner J; Mueller S; Meyding-Lamade U; Strobl R; Mansmann U; Schwab S; Steiner T
    Stroke; 2006 Jun; 37(6):1465-70. PubMed ID: 16675739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage.
    Dibu JR; Weimer JM; Ahrens C; Manno E; Frontera JA
    Neurocrit Care; 2016 Jun; 24(3):413-9. PubMed ID: 26545367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Symptomatic Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
    Akiyama H; Uchino K; Hasegawa Y
    PLoS One; 2015; 10(7):e0132900. PubMed ID: 26171862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
    Tsivgoulis G; Lioutas VA; Varelas P; Katsanos AH; Goyal N; Mikulik R; Barlinn K; Krogias C; Sharma VK; Vadikolias K; Dardiotis E; Karapanayiotides T; Pappa A; Zompola C; Triantafyllou S; Kargiotis O; Ioakeimidis M; Giannopoulos S; Kerro A; Tsantes A; Mehta C; Jones M; Schroeder C; Norton C; Bonakis A; Chang J; Alexandrov AW; Mitsias P; Alexandrov AV
    Neurology; 2017 Sep; 89(11):1142-1151. PubMed ID: 28814457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage.
    Tsivgoulis G; Wilson D; Katsanos AH; Sargento-Freitas J; Marques-Matos C; Azevedo E; Adachi T; von der Brelie C; Aizawa Y; Abe H; Tomita H; Okumura K; Hagii J; Seiffge DJ; Lioutas VA; Traenka C; Varelas P; Basir G; Krogias C; Purrucker JC; Sharma VK; Rizos T; Mikulik R; Sobowale OA; Barlinn K; Sallinen H; Goyal N; Yeh SJ; Karapanayiotides T; Wu TY; Vadikolias K; Ferrigno M; Hadjigeorgiou G; Houben R; Giannopoulos S; Schreuder FHBM; Chang JJ; Perry LA; Mehdorn M; Marto JP; Pinho J; Tanaka J; Boulanger M; Al-Shahi Salman R; Jäger HR; Shakeshaft C; Yakushiji Y; Choi PMC; Staals J; Cordonnier C; Jeng JS; Veltkamp R; Dowlatshahi D; Engelter ST; Parry-Jones AR; Meretoja A; Mitsias PD; Alexandrov AV; Ambler G; Werring DJ
    Ann Neurol; 2018 Nov; 84(5):694-704. PubMed ID: 30255970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial.
    Polymeris AA; Karwacki GM; Siepen BM; Schaedelin S; Tsakiris DA; Stippich C; Guzman R; Nickel CH; Sprigg N; Kägi G; Vehoff J; Barinka F; Thilemann S; Maurer M; Wagner B; Traenka C; Gensicke H; De Marchis GM; Bonati LH; Fischer U; Z'Graggen WJ; Nedeltchev K; Wegener S; Baumgartner P; Engelter ST; Seiffge DJ; Peters N; Lyrer PA;
    Stroke; 2023 Sep; 54(9):2223-2234. PubMed ID: 37466000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation Testing in Intracerebral Hemorrhage Related to Non-vitamin K Antagonist Oral Anticoagulants.
    Purrucker JC; Rizos T; Haas K; Wolf M; Khan S; Heuschmann PU; Veltkamp R;
    Neurocrit Care; 2017 Oct; 27(2):208-213. PubMed ID: 28477151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists.
    Alonso de Leciñana M; Huertas N; Egido JA; Muriel A; García A; Ruiz-Ares G; Díez-Tejedor E; Fuentes B
    Thromb Haemost; 2013 Dec; 110(6):1145-51. PubMed ID: 24030842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
    Boulouis G; Morotti A; Pasi M; Goldstein JN; Gurol ME; Charidimou A
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):263-270. PubMed ID: 29030422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.